These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29127699)

  • 41. Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):637-42. PubMed ID: 24477740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
    Mimae T; Miyata Y; Mimura T; Ito H; Nakayama H; Okumura S; Yoshimura M; Okada M
    Jpn J Clin Oncol; 2015 Aug; 45(8):767-73. PubMed ID: 26056324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma: A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma.
    Lee HY; Lee SW; Lee KS; Jeong JY; Choi JY; Kwon OJ; Song SH; Kim EY; Kim J; Shim YM
    J Thorac Oncol; 2015 Dec; 10(12):1785-94. PubMed ID: 26473646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.
    Lee HY; Lee KS
    J Thorac Imaging; 2011 May; 26(2):106-18. PubMed ID: 21508733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings.
    Tsutani Y; Miyata Y; Yamanaka T; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):17-23. PubMed ID: 23246051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [
    Moon JW; Song YH; Kim YN; Woo JY; Son HJ; Hwang HS; Lee SH
    Ann Nucl Med; 2024 Sep; 38(9):754-762. PubMed ID: 38795306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maximum Standardized Uptake Value on Positron Emission Tomography is Associated With More Advanced Disease and High-risk Features in Lung Adenocarcinoma.
    Koike T; Sato N; Hosoda Y; Tazawa M; Goto T; Sato S; Yamazaki M; Toyabe SI; Tsuchida M
    Semin Thorac Cardiovasc Surg; 2022; 34(3):1051-1060. PubMed ID: 34320398
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
    Muto J; Hida Y; Kaga K; Ohtaka K; Okamoto S; Tamaki N; Nakada-Kubota R; Hirano S; Matsui Y
    Anticancer Res; 2014 Feb; 34(2):805-10. PubMed ID: 24511016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness.
    Mimae T; Miyata Y; Tsutani Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
    JTCVS Open; 2022 Sep; 11():300-316. PubMed ID: 36172403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic role of positron emission tomography and computed tomography parameters in stage I lung adenocarcinoma.
    Carretta A; Bandiera A; Muriana P; Viscardi S; Ciriaco P; Gajate AMS; Arrigoni G; Lazzari C; Gregorc V; Negri G
    Radiol Oncol; 2020 May; 54(3):278-284. PubMed ID: 32463388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of positron emission tomography/computed tomography findings for adjuvant chemotherapy indications in stage T1b-2aN0M0 lung adenocarcinoma.
    Sasada S; Miyata Y; Tsubokawa N; Mimae T; Yoshiya T; Okada M
    Ann Thorac Surg; 2014 Aug; 98(2):417-22. PubMed ID: 24961842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of quantified metabolic activity in nonsmall cell lung cancer with tumor size and tumor pathological characteristics.
    Karam MB; Doroudinia A; Behzadi B; Mehrian P; Koma AY
    Medicine (Baltimore); 2018 Aug; 97(32):e11628. PubMed ID: 30095621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.
    Higashi K; Sakuma T; Ito K; Niho S; Ueda Y; Kobayashi T; Sekiguchi R; Takahashi T; Kato T; Tonami H
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):373-81. PubMed ID: 18931837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography.
    Nomori H; Kosaka N; Watanabe K; Ohtsuka T; Naruke T; Kobayashi T; Uno K
    Ann Thorac Surg; 2005 Dec; 80(6):2020-5. PubMed ID: 16305837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
    Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
    Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Correlation analysis between imaging features and lymph node metastasis in T1a lung adenocarcinoma].
    Ye B; Feng J; Pan XF; Yang Y; Geng JF; Cao KJ; Zhao H; Hu DZ
    Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):904-7. PubMed ID: 24433769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of preoperative prediction factors of tumor subtypes for patients with solitary ground-glass opacity pulmonary nodules.
    Li M; Wang Y; Chen Y; Zhang Z
    J Cardiothorac Surg; 2018 Jan; 13(1):9. PubMed ID: 29343293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.
    Higuchi M; Hasegawa T; Osugi J; Suzuki H; Gotoh M
    Ann Thorac Cardiovasc Surg; 2014; 20(3):185-91. PubMed ID: 23603641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of pathologic prognostic factors in patients with lung adenocarcinomas: comparison of thin-section computed tomography and positron emission tomography/computed tomography.
    Iwano S; Kishimoto M; Ito S; Kato K; Ito R; Naganawa S
    Cancer Imaging; 2014 Apr; 14(1):3. PubMed ID: 25609076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.